Nevertheless, because the results in human breast cancer tumors presented in this paper are well reflected in previous translational studies on LPP biology, this work supports the therapeutic potential of decreasing the expressions of LPP2 relative to LPP1/3 in breast and possibly other cancers, and encourages the future development of novel adjunct therapies. The gene discussed is PLPP2; the disease is cancer.